Martingale Asset Management’s Dynavax Technologies DVAX Stock Holding History

Martingale Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-83,993	Closed	-$1.29M	–	813
2025 Q4	$1.29M	Buy	+83,993	New	+$925K	0.03%	422
2025 Q2	–	Sell	-11,905	Closed	-$154K	–	803
2025 Q1	$154K	Hold	11,905	–	–	﹤0.01%	747
2024 Q4	$152K	Buy	+11,905	New	+$144K	﹤0.01%	747
2024 Q3	–	Sell	-11,311	Closed	-$127K	–	801
2024 Q2	$127K	Sell	11,311 -7,700	-41%	-$89.6K	﹤0.01%	773
2024 Q1	$236K	Buy	+19,011	New	+$248K	﹤0.01%	745
2021 Q2	–	Sell	-11,509	Closed	-$114K	–	848
2021 Q1	$114K	Buy	+11,509	New	+$94.9K	﹤0.01%	831

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Martingale Asset Management's DVAX Position: Q1 2026 in Review

Martingale Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 83,993 shares — an estimated $1.29M sold.

Martingale Asset Management first reported a position in DVAX in Q1 2021 and held it in 6 quarters. The position peaked at $1.29M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Martingale Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Martingale Asset Management sold 83,993 Dynavax Technologies shares in Q1 2026, an estimated $1.29M.
Martingale Asset Management first reported a position in Dynavax Technologies in Q1 2021 and held it in 6 quarters.
Martingale Asset Management's Dynavax Technologies position peaked at $1.29M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.